Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Parallel Session 4414

Update on Pediatric Hyperkinetic Disorders: What Adult Neurologists Should Know

Wednesday, October 8, 2025
14:00 - 15:30 | Room TBD

In this session, the faculty will discuss the spectrum of childhood-onset hyperkinetic disorders that continue into adulthood with focus on treatable disorders and indications for DBS.


Chairs:

Miryam Carecchio, Italy
Shekeeb Mohammad, Australia

Presenters:

Update on the Spectrum of Pediatric Hyperkinetic Disorders
Vrajesh Udani, India

Treatable Pediatric Hyperkinetic Disorders
Mohamed Babiker, United Arab Emirates

DBS: Who and When?
Giovanna Zorzi, Italy

CSPC Liaisons:

Manju Kurian, United Kingdom

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Discuss the spectrum of childhood-onset hyperkinetic disorders and continue into adulthood including paroxysmal (ATP1A3, ADCY5, KCNMA1) and dyskinesia-epilepsy spectrum disorders (GNAO1)
  2. Describe the spectrum of childhood-onset treatable hyperkinetic disorders and emerging precision therapies
  3. Approach diseases most amenable to deep brain stimulation and decide the ideal timing for DBS

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

Focus

Clinical